What Relaxo Footwears Bears Saw Before The Fall
If you bought Relaxo Footwears on the original thesis of data-led retail expansion, premiumization and e-commerce focus, the past year has been painful. Holding Relaxo Footwears over the past year would have meant a 36.3% loss, including dividends. That headline fall sits awkwardly beside later news that revenue and net income in Q1 2027 were higher than Q1 2026. If the starting case relied on premium sneakers, higher margins and distributor reforms, which of those moving parts was least prepared for how reality played out?
Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.
The easy part of this move is behind Relaxo Footwears. Zero in on 192 high quality undervalued stocks for companies trading below our estimates.
The Two Relaxo Footwears Stories Investors Were Pricing In
The shares cost ₹444 at the start of the period, and anyone looking at Relaxo Footwears then had to decide which story felt more convincing.
The bullish narrative put fair value at ₹477. It leaned on data-led distribution tools such as the Relaxo Parivaar app, along with premium sneakers and e-commerce, assuming these would support higher average selling prices and margin expansion over time.
The bearish view anchored fair value at ₹385. That case focused on reliance on low priced open footwear and exposure to weaker income consumers as a risk to future revenue and earnings stability.
What The Results Changed For Relaxo Footwears
Revenue for Relaxo Footwears in Q1 2027 reached ₹7,050.5m against ₹6,544.9m a year earlier, and net income moved to ₹549.4m from ₹489m. Net margin edged up from 7.5% to 7.8%. That mix of higher sales and slightly better profitability gave more weight to the bullish thesis than the cautious one, but it did not close the debate.
The key assumption on trial was that premiumization and channel reforms would eventually show up in cleaner profitability. For any other retailer, track whether margin percentage and absolute earnings move together when management promises mix upgrades and better quality revenue.
What The Share Price Drop Asks Of Relaxo Footwears Buyers Now
Relaxo Footwears trades at ₹279 today, after a 36.3% loss over the past year. The selected Narrative sees Fair Value above that level, based on a tax and distribution led uplift rather than just broad cost cuts.
The key question for anyone considering this fall is whether Relaxo can actually execute on premiumization and wider outlet reach without losing the volume growth that underpins the Narrative.
"GST 2.0 has lowered tax on footwear below ₹2,500 to 5% for more than 98% of Relaxo Footwears portfolio, which could allow the company to widen its reach into price sensitive mass and mid market buyers and support higher revenue over time as formal players take share from unorganized competitors."
The price and this Narrative do not agree. → Uncover what this Narrative says Relaxo Footwears is actually worth
Find Your Own Contrarian Opportunity
Passing on this one could have spared you a loss. Where might you find the opposite surprise? Start looking for companies whose prices leave room for a better outcome than investors expect. These three trade below our estimated value.
- Company 1 - 33% below our estimate - pursues more subsea projects using faster brownfield tiebacks and longer duration services contracts.
- Company 2 - 21% below our estimate - builds a dispersed legal platform where experienced lawyers shift to higher share of fees.
- Company 3 - 44% below our estimate - sells oncology planning software that shifts customers from one off licenses to recurring support revenue.
Those are three of them. See all 204 companies with the balance sheet to back it up →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com